Article Information
PubMed
Print ISSN
Online ISSN
History
- Received July 8, 2019
- Accepted August 28, 2019
- Published online October 10, 2019.
Article Versions
- Earlier version (September 6, 2019 - 12:33).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Xue-Qing Li,
- Gunnar Grönberg,
- Eva-Henriette Bangur,
- Martin A. Hayes,
- Neal Castagnoli Jr., and
- Lars Weidolf
- Drug Metabolism and Pharmacokinetics, Research and Early Development Cardiovascular, Renal and Metabolism (X.-Q.L., E.-H.B., L.W.), Hit Discovery, Discovery Sciences (M.A.H.), and Medicinal Chemistry, Early Respiratory, Inflammation and Autoimmunity (G.G.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and Department of Chemistry, Virginia Tech, Blacksburg, Virginia (N.C.J.)
- Address correspondence to:
Dr. Lars Weidolf, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. E-mail: lars.weidolf{at}astrazeneca.com